Hector Esquer
Papers
1
Total Citations
7
H-Index
1
About
Dr. Hector Esquer is a cancer researcher whose work focuses on the discovery and development of novel therapeutic strategies, particularly targeting DNA damage repair pathways. His key research areas include high-throughput screening (HTS) for drug discovery, PARP biology, and overcoming resistance mechanisms in cancer therapy. Dr. Esquer’s major contribution is the identification of inhibitors targeting the PARP1-HPF1 complex, a breakthrough that addresses the limitations of current PARP inhibitors (PARPi). While PARPi are effective against BRCA-deficient cancers, their success is limited in other contexts and diminished by resistance. By targeting the PARP1-HPF1 interaction, Dr. Esquer’s work opens new avenues for treating a broader range of cancers, including those resistant to existing therapies. His 2023 paper on this topic has already garnered 7 citations, reflecting its early impact. This research is particularly notable for its potential to expand the clinical utility of PARP inhibitors beyond BRCA-mutated tumors. Dr. Esquer’s innovative approach to drug discovery and his focus on overcoming therapeutic resistance mark him as a promising young investigator in the field of cancer pharmacology.
Research Focus
Key Achievements
Top Papers
- 1HTS discovery of PARP1-HPF1 complex inhibitors in cancer7 citations · 2023